Lumbar Degenerative Disc Disease Market to Grow with a CAGR of 6.65% through 2028
Improved access to healthcare and a growing awareness
of spinal health is expected to drive the Global Lumbar Degenerative Disc
Disease Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Lumbar
Degenerative Disc Disease Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Lumbar
Degenerative Disc Disease Market stood at USD 8.82 billion in 2022 and is
anticipated to grow with a CAGR of 6.65% in the forecast period, 2024-2028.Lumbar
Degenerative Disc Disease (DDD) is a widespread and debilitating spinal
condition that affects millions of people worldwide. It results from the
gradual deterioration of intervertebral discs in the lower back, causing
chronic pain, reduced mobility, and a substantial decline in the quality of
life. As the world's population continues to age and lifestyles become
increasingly sedentary, the prevalence of Lumbar DDD is on the rise. One of the
most significant drivers behind the growth of the Lumbar DDD market is the
global aging population. As individuals age, their spinal discs naturally
degenerate, making them more susceptible to Lumbar DDD. The elderly population
is projected to grow substantially in the coming years, particularly in
developed countries. This demographic shift is expected to result in an
increased number of Lumbar DDD cases, creating a robust market for diagnostic,
therapeutic, and surgical solutions.
Improved access to healthcare and a growing awareness
of spinal health have led to an increase in the diagnosis of Lumbar DDD. People
are now more likely to seek medical attention for back pain and related
symptoms, leading to early detection and intervention. Diagnostic tools such as
magnetic resonance imaging (MRI) and computed tomography (CT) scans have become
more accessible and accurate, enabling healthcare professionals to diagnose
Lumbar DDD effectively. This rise in awareness and diagnosis has contributed
significantly to the market's expansion. The Lumbar DDD market has seen a surge
in minimally invasive treatment options, offering patients less invasive
alternatives to traditional surgical procedures. Techniques such as epidural
steroid injections, facet joint injections, and radiofrequency ablation provide
effective pain relief and improved quality of life for many patients without
the need for surgery. These less invasive treatments not only reduce patient
discomfort but also decrease recovery times and healthcare costs, making them
an attractive option for both patients and healthcare providers. For patients
with severe Lumbar DDD, surgical intervention remains a crucial treatment
option. Recent advancements in surgical techniques, such as spinal fusion and
artificial disc replacement, have revolutionized the field. These procedures
are now safer, more effective, and less invasive than ever before. Innovative
surgical implants, such as artificial discs and bone graft substitutes, have
improved patient outcomes and reduced the risk of complications. These
advancements have bolstered the surgical segment of the Lumbar DDD market.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Lumbar Degenerative Disc Disease Market”
The pharmaceutical industry plays a vital role in
managing Lumbar DDD. Medications for pain management, anti-inflammatory drugs,
and biologics are commonly prescribed to alleviate symptoms and improve
patients' quality of life. Pharmaceutical companies are continually researching
and developing new medications and therapies tailored to address the specific
needs of Lumbar DDD patients. As these treatments become more effective and
targeted, they contribute to the overall growth of the market. Technological
innovation has been a driving force behind the growth of the Lumbar DDD market.
Advances in medical imaging, such as 3D reconstruction and computer-assisted
navigation, have enhanced the accuracy of diagnosis and surgical planning.
Robotics-assisted surgery is also gaining momentum, offering surgeons greater
precision and control during procedures. These technologies improve patient
outcomes, reduce the risk of complications, and contribute to the overall
expansion of the market.
The Global Lumbar Degenerative Disc Disease Market is
segmented into derived Treatment Type, Route of administration, end user, regional
distribution, and company.
Based on Treatment Type, the Global Lumbar
Degenerative Disc Disease Market is segmented into Drug
Development, Regenerative Medicine, Toxicity Testing, Tissue Engineering, Cell
Therapy, and Disease Modeling. Based on the Treatment Type,
the drug treatment segment emerged as the dominant player in the global market
for Global Lumbar Degenerative Disc Disease in 2022. This is primarily because
drug therapy encompasses a broad range of medications, including pain
relievers, anti-inflammatory drugs, muscle relaxants, and neuropathic pain
medications, which can effectively manage the symptoms associated with Lumbar
DDD. Drug
treatments are generally non-invasive and do not require surgical procedures.
This makes them a less intimidating and more accessible option for many
patients. Surgical interventions are typically considered when conservative
treatments like drug therapy fail to provide sufficient relief.
Based on end user, the Global Lumbar Degenerative Disc
Disease Market is segmented into Hepatocytes,
Fibroblasts, Keratinocytes, Neurons, and Others. Based on the
Route of administration, the oral segment emerged as the dominant player in the
global market for Global Lumbar Degenerative Disc Disease in 2022. Oral
medications are convenient and easy for patients to self-administer. They can
be taken at home without the need for medical supervision, which makes them a
practical choice for long-term treatment. Oral administration does not require
needles or injections, which can be uncomfortable or intimidating for some patients.
It is a less invasive route, and many individuals are more comfortable taking
medications in pill or tablet form. There is a wide variety of oral medications
available for treating Lumbar DDD. This includes over-the-counter pain
relievers like nonsteroidal anti-inflammatory drugs (NSAIDs), muscle relaxants,
neuropathic pain medications, and prescription-strength pain relievers. The
versatility of oral medications allows healthcare providers to tailor treatment
plans to individual patient needs.
North America emerged as the dominant player in the
global Lumbar Degenerative Disc Disease market in 2022, holding the largest
market share. The region is equipped with state-of-the-art medical facilities,
advanced diagnostic tools, and a large pool of skilled healthcare
professionals. This infrastructure supports the early diagnosis and
comprehensive management of Lumbar DDD. North America is at the forefront of technological
innovation in the healthcare sector. The region has access to cutting-edge
medical technologies, including advanced imaging techniques, minimally invasive
surgical procedures, and robotic-assisted surgery. These innovations enhance
the accuracy and effectiveness of Lumbar DDD diagnosis and treatment.
Major companies operating in Global Lumbar
Degenerative Disc Disease Market are:
- Sorrento Therapeutics
- Spine Thera
- Eliem Therapeuticsa
- Scilex Holding
- Sinfonia Biotherapeutics
- Seikagaku Corporation
- Kolon life Science
- Vita Sciences
- Aurobindo Pharma
- Le Neurotech
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global Lumbar Degenerative Disc Disease (DDD)
market is poised for significant growth in the coming years, driven by several
key factors. Firstly, the aging population worldwide is expected to play a
pivotal role as Lumbar DDD is more prevalent among older individuals. With a
rising number of elderly individuals seeking treatment, the demand for
diagnostic services, medications, and surgical interventions is expected to increase
substantially. Besides, ongoing advancements in medical technology and surgical
techniques are enhancing the efficacy and safety of Lumbar DDD treatments.
Innovations such as minimally invasive procedures, robotics-assisted surgery,
and 3D imaging are improving patient outcomes and reducing recovery times,
making these treatments more attractive and accessible. Additionally, the
rising awareness and understanding of Lumbar DDD, both among healthcare
professionals and the general population, are contributing to early diagnosis
and intervention. This heightened awareness is crucial for addressing the
condition promptly and preventing its progression. ” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Treatment Type (Drug
Treatment, Biologics, Other), By Route of administration (Oral, Injectables,
Other), By End User (Hospitals & Clinics, Ambulatory Care Centres, Others),
By Region and Competition”, has evaluated the future growth potential of Global
Lumbar Degenerative Disc Disease Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Lumbar Degenerative Disc Disease Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website:
www.techsciresearch.com